Niclas Sjögren

456 total citations
17 papers, 351 citations indexed

About

Niclas Sjögren is a scholar working on Molecular Biology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Niclas Sjögren has authored 17 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Psychiatry and Mental health and 3 papers in Physiology. Recurrent topics in Niclas Sjögren's work include Dementia and Cognitive Impairment Research (4 papers), Pain Mechanisms and Treatments (2 papers) and Computational Drug Discovery Methods (2 papers). Niclas Sjögren is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Pain Mechanisms and Treatments (2 papers) and Computational Drug Discovery Methods (2 papers). Niclas Sjögren collaborates with scholars based in Sweden, United Kingdom and United States. Niclas Sjögren's co-authors include Gwenael Guillard, Sarah R. Kingsbury, M.A. Bowes, Alan Brett, Åsa Jansson, Philip G. Conaghan, John Öhd, Richard C. Bethell, B. Hägglöf and Lucy Gee and has published in prestigious journals such as Annals of Internal Medicine, NeuroImage and Experimental Neurology.

In The Last Decade

Niclas Sjögren

16 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niclas Sjögren Sweden 8 102 95 80 60 52 17 351
Bérenger Largeau France 10 84 0.8× 50 0.5× 114 1.4× 32 0.5× 87 1.7× 25 479
Brittany L. Adler United States 13 131 1.3× 81 0.9× 147 1.8× 24 0.4× 43 0.8× 31 570
Nikolaos Sfikas Switzerland 10 74 0.7× 56 0.6× 100 1.3× 50 0.8× 27 0.5× 23 350
Rongwei Zhang China 13 68 0.7× 62 0.7× 127 1.6× 13 0.2× 34 0.7× 28 432
Nobuaki Takeshita Japan 12 150 1.5× 53 0.6× 132 1.6× 51 0.8× 12 0.2× 28 361
Shu Jiang United States 15 115 1.1× 32 0.3× 142 1.8× 18 0.3× 114 2.2× 58 586
Jong‐Jer Lee Taiwan 16 53 0.5× 32 0.3× 183 2.3× 29 0.5× 14 0.3× 34 657
Masaya Enomoto Japan 8 19 0.2× 89 0.9× 99 1.2× 27 0.5× 33 0.6× 19 477
Margaret Scott United Kingdom 9 98 1.0× 24 0.3× 38 0.5× 80 1.3× 122 2.3× 13 376
Kateryna Sopova Germany 14 153 1.5× 17 0.2× 117 1.5× 29 0.5× 35 0.7× 30 497

Countries citing papers authored by Niclas Sjögren

Since Specialization
Citations

This map shows the geographic impact of Niclas Sjögren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niclas Sjögren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niclas Sjögren more than expected).

Fields of papers citing papers by Niclas Sjögren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niclas Sjögren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niclas Sjögren. The network helps show where Niclas Sjögren may publish in the future.

Co-authorship network of co-authors of Niclas Sjögren

This figure shows the co-authorship network connecting the top 25 collaborators of Niclas Sjögren. A scholar is included among the top collaborators of Niclas Sjögren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niclas Sjögren. Niclas Sjögren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Plummer, Ruth, Alastair Greystoke, Debashis Sarker, et al.. (2024). A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases. Journal of Hepatocellular Carcinoma. Volume 11. 2033–2047. 2 indexed citations
2.
Conaghan, Philip G., Sarah R. Kingsbury, Allan S. Brett, et al.. (2019). Safety and efficacy of six months' open label extension post-RCT using the novel cathepsin K inhibitor MIV-711 in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 27. S501–S502. 2 indexed citations
3.
Conaghan, Philip G., M.A. Bowes, Sarah R. Kingsbury, et al.. (2019). Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis. Annals of Internal Medicine. 172(2). 86–95. 108 indexed citations
4.
Hannesdóttir, Kristín, Tim Ashwood, Niclas Sjögren, et al.. (2013). P2–283: Psychometric features of the ADAS‐Cog: Identifying a potential cognition endpoint for prodromal Alzheimer's disease. Alzheimer s & Dementia. 9(4S_Part_11). 2 indexed citations
5.
Sjögren, Niclas, et al.. (2013). Effective visualization of integrated knowledge and data to enable informed decisions in drug development and translational medicine. Journal of Translational Medicine. 11(1). 250–250. 7 indexed citations
6.
Hannesdóttir, Kristín, Judith Jaeger, Peter Annas, et al.. (2013). Psychometric evaluation of ADAS-Cog and NTB for measuring drug response. Acta Neurologica Scandinavica. 129(2). 114–122. 32 indexed citations
7.
Nordin, Love Engström, Tie‐Qiang Li, Patrik Johansson, et al.. (2012). Cortical responses to amphetamine exposure studied by pCASL MRI and pharmacokinetic/pharmacodynamic dose modeling. NeuroImage. 68. 75–82. 12 indexed citations
8.
Schley, Marcus, Ayşe Kaçar Bayram, Roman Rukwied, et al.. (2012). Skin innervation at different depths correlates with small fibre function but not with pain in neuropathic pain patients. European Journal of Pain. 16(10). 1414–1425. 38 indexed citations
9.
Schmidt, Roland, B. Hägglöf, Rolf Karlsten, et al.. (2011). Structural and functional differences between neuropathy with and without pain?. Experimental Neurology. 231(2). 199–206. 48 indexed citations
11.
Lindblom, Per Henrik, Anna‐Lena Berg, Hui Zhang, et al.. (2011). Tesaglitazar, a Dual PPAR-α/γ Agonist, Hamster Carcinogenicity, Investigative Animal and Clinical Studies. Toxicologic Pathology. 40(1). 18–32. 5 indexed citations
12.
Simmons, Andrew, Michael Bauer, Yi Zhang, et al.. (2011). Cluster analysis of MR imaging in Alzheimer’s disease using decision tree refinement. Research Portal (King's College London). 6. 90–99. 7 indexed citations
13.
Spenger, Christian, Simon Fristed Eskildsen, Niclas Sjögren, et al.. (2011). P1‐352: Cortical atrophy rates in Alzheimer's disease and mild cognitive impairment from the ADNI study. Alzheimer s & Dementia. 7(4S_Part_6). 1 indexed citations
14.
Gonzalez, Henrik, Kerstin Nilsson, Niclas Sjögren, et al.. (2008). Identification of novel candidate protein biomarkers for the post-polio syndrome — Implications for diagnosis, neurodegeneration and neuroinflammation. Journal of Proteomics. 71(6). 670–681. 38 indexed citations
15.
Hellmold, Heike, Hui Zhang, Jan Andersson, et al.. (2007). Tesaglitazar, a PPARα/γ Agonist, Induces Interstitial Mesenchymal Cell DNA Synthesis and Fibrosarcomas in Subcutaneous Tissues in Rats. Toxicological Sciences. 98(1). 63–74. 28 indexed citations
16.
Hultin‐Rosenberg, Lina, Sujatha Jagannathan, Kerstin Nilsson, et al.. (2006). Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes. Xenobiotica. 36(10-11). 1122–1139. 18 indexed citations
17.
Sjögren, Niclas & Olivier Guilbaud. (2004). Comparison of Within‐Subject Covariance Matrices in 2 × 2 Crossover Trials with Multivariate Response. Scandinavian Journal of Statistics. 31(4). 603–612.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026